======= NMRK2 ======= == Gene Information == * **Official Symbol**: NMRK2 * **Official Name**: nicotinamide riboside kinase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27231|27231]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPI5|Q9NPI5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NMRK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NMRK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608705|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the phosphorylation of nicotinamide riboside (NR) and nicotinic acid riboside (NaR) to form nicotinamide mononucleotide (NMN) and nicotinic acid mononucleotide (NaMN). Reduces laminin matrix deposition and cell adhesion to laminin, but not to fibronectin. Involved in the regulation of PXN at the protein level and of PXN tyrosine phosphorylation. May play a role in the regulation of terminal myogenesis. {ECO:0000269|PubMed:10613898, ECO:0000269|PubMed:15137942}. No Pfam Domain information is available for this gene. |ribosylnicotinate kinase activity| |ribosylnicotinamide kinase activity| |negative regulation of myoblast differentiation| |NAD biosynthetic process| |nicotinamide nucleotide biosynthetic process| |pyridine nucleotide biosynthetic process| |pyridine nucleotide metabolic process| |nicotinamide nucleotide metabolic process| |pyridine-containing compound biosynthetic process| |pyridine-containing compound metabolic process| |NAD metabolic process| |oxidoreduction coenzyme metabolic process| |regulation of myoblast differentiation| |coenzyme biosynthetic process| |cofactor biosynthetic process| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |coenzyme metabolic process| |cofactor metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |intracellular membrane-bounded organelle| |negative regulation of cell differentiation| |organophosphate metabolic process| |negative regulation of developmental process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |phosphorylation| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.58| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.92| |[[:results:exp480|ETC-159 50μM R08 exp480]]|-1.77| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7678 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}